BBC’s George Alagiah to take break from TV after most cancers unfold – The Guardian

BBC’s George Alagiah to take break from TV after most cancers unfold – The Guardian

George Alagiah

Newsreader’s agent says he may have chemotherapy and radiotherapy and is ‘decided to return again’

PA Media

Mon 18 Oct 2021 13.54 BST

The newsreader George Alagiah is to take a break from his presenting duties on the BBC as he offers with “an extra unfold of most cancers”, his agent has stated.

The TV journalist, 65, was first recognized with the sickness in 2014 and once more in 2017.

Alagiah had returned to tv on the BBC Information at Six following his earlier therapy.

However an announcement from Alagiah’s agent stated he was “to take a break from studio duties to take care of an extra unfold of most cancers”.

She added: “He was first recognized with stage four bowel most cancers in April 2014. In a letter to colleagues within the newsroom Mr Alagiah stated his medical crew had determined to hit the brand new tumour ‘laborious and quick’.

“He is because of endure a mixture of chemotherapy and radiotherapy over the following few months.

“He added that engaged on the programme ‘has saved me sane over the previous few years’ and, ‘I’m decided to return again.’”

Alagiah underwent 17 rounds of chemotherapy to deal with his superior bowel most cancers in 2014. He returned to presenting duties in 2015 after making progress towards the illness, and stated he was a “richer particular person” for it.

His most cancers returned in December 2017, and the presenter underwent additional therapy earlier than as soon as once more returning to work.

Final 12 months, he examined optimistic for coronavirus after deciding to cease showing within the studio throughout the outbreak following recommendation from docs and colleagues.

#ticker

topRight

bottomRight

/goalExceededMarkerPercentage

/ticker

.


#choiceCards

We might be in contact to remind you to contribute. Look out for a message in your inbox in . When you’ve got any questions on contributing, please contact us.

Leave a Reply

Your email address will not be published. Required fields are marked *